Editorial: Repeatability data on vibration‐controlled transient elastography and magnetic resonance elastography and their relevance for drug development and clinical practice in patients with cirrhosis-Reference-Cited by-同舟云学术

Editorial: Repeatability data on vibration‐controlled transient elastography and magnetic resonance elastography and their relevance for drug development and clinical practice in patients with cirrhosis

Published:2024-08-29 Issue:7 Volume:60 Page:953-954
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Petroff David¹^ORCID,Messer Eva²,Karlas Thomas³^ORCID,Wiegand Johannes²^ORCID

Affiliation:

1. Clinical Trial Centre Leipzig Leipzig University Leipzig Germany

2. Division of Hepatology, Department of Medicine II Leipzig University Medical Centre Leipzig Germany

3. Division of Gastroenterology, Department of Medicine II Leipzig University Medical Centre Leipzig Germany

Abstract

LINKED CONTENTThis article is linked to Siddiqi et al paper. To view this article, visit https://doi.org/10.1111/apt.18118

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.18137

Reference5 articles.

1. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

2. Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: a prospective study;Siddiqi H;Aliment Pharmacol Ther,2024

3. Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis

4. Prognostic significance of a change in liver stiffness measurement by vibration‐controlled transient elastography‐a multicenter cohort study of 10, 920 patients with metabolic dysfunctionassociated steatotic liver disease (MASLD);Yip TCF;J Hepatol,2024

5. Collaboration, Not Competition: The Role of Magnetic Resonance, Transient Elastography, and Liver Biopsy in the Diagnosis of Nonalcoholic Fatty Liver Disease